Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Nicole Gonzales

Concepts (309)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cerebral Hemorrhage
27
2024
125
4.210
Why?
Stroke
39
2025
1287
3.250
Why?
Neurology
6
2026
107
2.390
Why?
Tissue Plasminogen Activator
23
2024
245
2.020
Why?
Brain Ischemia
19
2025
362
1.690
Why?
Fibrinolytic Agents
17
2024
303
1.510
Why?
Thrombolytic Therapy
14
2024
165
1.390
Why?
Sexism
1
2024
70
0.780
Why?
Hematoma
6
2015
62
0.760
Why?
Ischemic Attack, Transient
1
2023
71
0.740
Why?
Endarterectomy, Carotid
4
2015
63
0.680
Why?
Education, Medical
1
2024
274
0.640
Why?
Platelet Aggregation Inhibitors
3
2022
499
0.630
Why?
Women
1
2020
46
0.630
Why?
Carotid Stenosis
4
2014
103
0.620
Why?
Decompressive Craniectomy
1
2019
9
0.600
Why?
Medicine
1
2020
127
0.560
Why?
Matrix Metalloproteinases
1
2019
95
0.550
Why?
Stents
5
2015
554
0.530
Why?
Time-to-Treatment
2
2021
257
0.530
Why?
Mobile Health Units
3
2024
21
0.510
Why?
Percutaneous Coronary Intervention
1
2022
550
0.500
Why?
Angioplasty
2
2014
49
0.490
Why?
Attention
1
2020
463
0.480
Why?
Brain Injuries
1
2020
499
0.430
Why?
Cerebral Revascularization
1
2014
22
0.420
Why?
Emergency Medical Services
5
2024
680
0.400
Why?
Aged
39
2024
26432
0.400
Why?
Humans
70
2026
146342
0.390
Why?
Diffusion Tensor Imaging
2
2024
83
0.390
Why?
Treatment Outcome
28
2023
11821
0.380
Why?
Middle Aged
42
2025
36619
0.370
Why?
Cerebral Ventricles
3
2024
56
0.370
Why?
Hypertension
3
2016
1272
0.350
Why?
Thiazolidinediones
2
2012
142
0.350
Why?
Female
48
2026
79499
0.310
Why?
Health Education
4
2023
346
0.310
Why?
Male
49
2025
73396
0.300
Why?
Disability Evaluation
3
2021
297
0.300
Why?
Clinical Trials as Topic
6
2023
1064
0.270
Why?
Prospective Studies
14
2024
8123
0.270
Why?
Aged, 80 and over
19
2024
8391
0.260
Why?
Schools
2
2007
436
0.250
Why?
Time Factors
12
2025
7109
0.240
Why?
Risk Factors
10
2025
10921
0.230
Why?
Awareness
1
2007
113
0.230
Why?
Demyelinating Autoimmune Diseases, CNS
1
2005
4
0.230
Why?
Paraneoplastic Syndromes, Nervous System
1
2005
14
0.230
Why?
Encephalomyelitis, Acute Disseminated
1
2005
11
0.220
Why?
Cerebral Blood Volume
1
2024
5
0.210
Why?
Lactation
1
2026
193
0.210
Why?
Cerebral Intraventricular Hemorrhage
1
2024
6
0.210
Why?
Anticoagulants
3
2019
746
0.210
Why?
Healthcare Disparities
2
2024
733
0.200
Why?
Workplace
1
2026
268
0.200
Why?
American Heart Association
2
2023
364
0.190
Why?
Skin Diseases, Vesiculobullous
1
2003
15
0.190
Why?
Herpesvirus 2, Human
1
2003
27
0.190
Why?
Encephalitis, Herpes Simplex
1
2003
21
0.190
Why?
Pyramidal Tracts
1
2023
30
0.190
Why?
Cytochrome P-450 CYP2C19
1
2022
29
0.190
Why?
Antihypertensive Agents
3
2016
519
0.180
Why?
Ambulances
2
2021
52
0.180
Why?
Pilot Projects
5
2023
1888
0.180
Why?
Academic Medical Centers
2
2024
561
0.180
Why?
Hypoglycemic Agents
1
2012
1412
0.180
Why?
Health Status Disparities
1
2025
322
0.170
Why?
Heterozygote
1
2022
311
0.170
Why?
PPAR gamma
3
2014
182
0.170
Why?
Databases, Factual
3
2019
1493
0.170
Why?
Postoperative Complications
1
2014
3034
0.170
Why?
Adult
19
2025
41087
0.170
Why?
Prognosis
6
2025
4351
0.170
Why?
Retrospective Studies
16
2025
17438
0.160
Why?
Neuroprotective Agents
2
2015
146
0.160
Why?
Health Promotion
2
2007
786
0.160
Why?
Faculty, Medical
1
2024
309
0.160
Why?
Anxiety Disorders
1
2023
354
0.160
Why?
Sex Factors
4
2025
2107
0.160
Why?
United States
10
2024
16136
0.150
Why?
Factor VIIa
2
2011
43
0.150
Why?
Inpatients
1
2024
540
0.150
Why?
Pipecolic Acids
2
2012
26
0.150
Why?
Aspirin
1
2022
405
0.150
Why?
Schools, Medical
1
2020
158
0.150
Why?
Predictive Value of Tests
4
2019
2113
0.150
Why?
Overweight
1
2023
614
0.140
Why?
Recovery of Function
3
2019
725
0.140
Why?
Isoenzymes
1
2019
294
0.140
Why?
Edema
1
2019
131
0.130
Why?
Glasgow Coma Scale
1
2019
211
0.130
Why?
Adenocarcinoma
1
2005
927
0.130
Why?
Dose-Response Relationship, Drug
4
2012
2022
0.130
Why?
Health Services Needs and Demand
1
2020
287
0.130
Why?
Mexican Americans
2
2009
119
0.130
Why?
Disease Progression
3
2013
2867
0.130
Why?
Genotype
1
2022
1879
0.130
Why?
NF-E2-Related Factor 2
2
2015
96
0.130
Why?
Propensity Score
1
2019
376
0.130
Why?
Communication
1
2024
980
0.130
Why?
Injury Severity Score
1
2019
572
0.120
Why?
Hospital Mortality
2
2019
1051
0.120
Why?
Platelet Transfusion
1
2017
76
0.120
Why?
Severity of Illness Index
8
2024
2921
0.120
Why?
Ultrasonography, Doppler, Transcranial
3
2013
48
0.120
Why?
Anxiety
1
2023
1125
0.120
Why?
Decision Making
1
2023
993
0.120
Why?
Tomography, X-Ray Computed
4
2021
2786
0.110
Why?
Texas
4
2013
280
0.110
Why?
Fumarates
1
2015
10
0.110
Why?
Microglia
2
2008
289
0.110
Why?
Quality of Health Care
1
2020
702
0.110
Why?
Anti-Inflammatory Agents
2
2011
474
0.110
Why?
Pneumonia, Viral
1
2020
387
0.110
Why?
Coronavirus Infections
1
2020
379
0.110
Why?
Recombinant Proteins
4
2011
1361
0.110
Why?
Antithrombins
2
2013
71
0.110
Why?
Retinoid X Receptors
1
2014
42
0.110
Why?
Blood Pressure
3
2011
1765
0.110
Why?
Intraoperative Complications
1
2015
157
0.100
Why?
Risk Assessment
2
2025
3712
0.100
Why?
Cerebral Infarction
1
2014
46
0.100
Why?
Neutrophil Infiltration
1
2014
107
0.100
Why?
Single-Blind Method
1
2014
313
0.100
Why?
Cohort Studies
7
2022
6077
0.100
Why?
Odds Ratio
3
2021
1077
0.100
Why?
Delivery of Health Care
1
2020
947
0.090
Why?
Follow-Up Studies
4
2017
5439
0.090
Why?
Quality Control
1
2013
163
0.090
Why?
Perioperative Care
1
2015
235
0.090
Why?
Registries
3
2025
2400
0.090
Why?
Medical Records
1
2013
193
0.090
Why?
Sulfonamides
3
2012
594
0.090
Why?
Genetic Predisposition to Disease
1
2021
2488
0.090
Why?
Biomarkers
2
2019
4340
0.090
Why?
Surveys and Questionnaires
2
2026
6073
0.090
Why?
Lung Neoplasms
1
2005
2675
0.090
Why?
Carotid Artery, Internal
1
2011
45
0.090
Why?
Telemedicine
2
2020
966
0.090
Why?
Cyclooxygenase 2 Inhibitors
1
2011
24
0.080
Why?
Cerebral Amyloid Angiopathy
1
2011
11
0.080
Why?
Celecoxib
1
2011
41
0.080
Why?
Collagen Type IV
1
2011
26
0.080
Why?
Neurosurgical Procedures
1
2013
209
0.080
Why?
Exercise
1
2023
2213
0.080
Why?
Carotid Arteries
1
2012
206
0.080
Why?
Nervous System Diseases
1
2014
288
0.080
Why?
Brain Edema
1
2011
63
0.080
Why?
History, 20th Century
1
2012
330
0.080
Why?
NF-kappa B
1
2014
674
0.080
Why?
Universities
1
2013
451
0.080
Why?
Injections, Intra-Arterial
4
2013
25
0.080
Why?
Nephrology
1
2011
59
0.080
Why?
Platelet Glycoprotein GPIIb-IIIa Complex
1
2009
25
0.080
Why?
Treatment Failure
2
2014
361
0.070
Why?
Double-Blind Method
2
2012
2070
0.070
Why?
Heparin
1
2011
247
0.070
Why?
Health Care Surveys
1
2011
541
0.070
Why?
Resuscitation Orders
1
2009
48
0.070
Why?
Research Design
2
2013
1143
0.070
Why?
Hand Transplantation
1
2008
9
0.070
Why?
Intracranial Thrombosis
1
2008
19
0.070
Why?
Venous Thrombosis
1
2011
199
0.070
Why?
Caffeine
1
2009
77
0.070
Why?
Hand Injuries
1
2008
31
0.070
Why?
Adolescent
8
2025
22557
0.070
Why?
Endovascular Procedures
1
2013
390
0.070
Why?
Neutrophils
1
2014
1133
0.070
Why?
Embolism
1
2008
49
0.070
Why?
Hypothermia, Induced
1
2009
96
0.070
Why?
Pyrazoles
1
2011
517
0.060
Why?
Quality Improvement
1
2016
1354
0.060
Why?
Practice Patterns, Physicians'
2
2017
1408
0.060
Why?
Renal Dialysis
1
2011
461
0.060
Why?
Nerve Fibers, Myelinated
1
2005
47
0.060
Why?
Methylprednisolone
1
2005
58
0.050
Why?
Organ Transplantation
1
2008
244
0.050
Why?
Emergency Treatment
1
2006
122
0.050
Why?
Heart Diseases
1
2008
343
0.050
Why?
Kidney Failure, Chronic
1
2011
589
0.050
Why?
Teaching
1
2007
244
0.050
Why?
Paralysis
1
2005
69
0.050
Why?
Brain Stem
1
2005
101
0.050
Why?
Phagocytosis
3
2014
298
0.050
Why?
Injections, Intravenous
3
2011
197
0.050
Why?
Muscle Weakness
1
2005
93
0.050
Why?
Fatal Outcome
1
2005
302
0.050
Why?
Program Development
1
2007
371
0.050
Why?
Quality-Adjusted Life Years
1
2024
122
0.050
Why?
Administration, Intravenous
2
2017
172
0.050
Why?
Young Adult
3
2025
14330
0.050
Why?
Case-Control Studies
3
2021
3647
0.050
Why?
Ethanol
1
2009
630
0.050
Why?
Diffusion Magnetic Resonance Imaging
1
2005
158
0.050
Why?
Chi-Square Distribution
2
2017
517
0.050
Why?
Emergency Service, Hospital
1
2016
2363
0.050
Why?
Peptides
1
2009
992
0.050
Why?
Meningitis, Aseptic
1
2003
13
0.050
Why?
Growth and Development
1
2023
9
0.050
Why?
Principal Component Analysis
1
2023
192
0.050
Why?
Spinal Cord
1
2005
378
0.050
Why?
Hemorrhage
2
2023
825
0.050
Why?
Headache
1
2003
150
0.040
Why?
Catalase
2
2014
133
0.040
Why?
Age Factors
2
2025
3347
0.040
Why?
Students
1
2007
649
0.040
Why?
Acute Disease
3
2011
1038
0.040
Why?
Cost-Benefit Analysis
1
2024
640
0.040
Why?
Certification
1
2023
118
0.040
Why?
Respiratory Insufficiency
1
2005
330
0.040
Why?
Partial Thromboplastin Time
2
2012
53
0.040
Why?
Brain
1
2014
2991
0.040
Why?
Reperfusion
2
2013
53
0.040
Why?
DNA, Viral
1
2003
354
0.040
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2003
974
0.040
Why?
Practice Guidelines as Topic
3
2017
1591
0.040
Why?
Macrophages
1
2008
1532
0.040
Why?
Hospital Bed Capacity
1
2020
28
0.040
Why?
Guideline Adherence
2
2017
594
0.040
Why?
Health Care Rationing
1
2020
54
0.040
Why?
Ethics, Medical
1
2020
90
0.040
Why?
Kaplan-Meier Estimate
2
2012
970
0.040
Why?
Rats, Sprague-Dawley
2
2015
2537
0.040
Why?
Health Resources
1
2020
131
0.040
Why?
Magnetic Resonance Imaging
3
2023
3926
0.030
Why?
Caregivers
1
2007
1080
0.030
Why?
Logistic Models
2
2017
2126
0.030
Why?
Incidence
1
2025
2936
0.030
Why?
CD36 Antigens
2
2008
32
0.030
Why?
Combined Modality Therapy
2
2013
1271
0.030
Why?
Arginine
2
2012
264
0.030
Why?
Hospitals
1
2023
738
0.030
Why?
Autoantibodies
1
2005
1500
0.030
Why?
Ventriculostomy
1
2017
24
0.030
Why?
Betacoronavirus
1
2020
288
0.030
Why?
Drug Therapy, Combination
2
2012
1036
0.030
Why?
Statistics, Nonparametric
1
2017
426
0.030
Why?
Rats
2
2015
5586
0.030
Why?
Dimethyl Fumarate
1
2015
9
0.030
Why?
Thrombocytopenia
1
2017
206
0.030
Why?
Longitudinal Studies
1
2023
3017
0.030
Why?
Disease Models, Animal
3
2014
4580
0.030
Why?
Body Mass Index
1
2023
2458
0.030
Why?
Neuroimmunomodulation
1
2014
67
0.030
Why?
Perfusion Imaging
1
2014
66
0.020
Why?
Intensive Care Units
1
2020
925
0.020
Why?
Multivariate Analysis
1
2017
1543
0.020
Why?
Biomedical Research
1
2020
729
0.020
Why?
Sex Distribution
1
2014
382
0.020
Why?
Animals
5
2015
38107
0.020
Why?
Tomography Scanners, X-Ray Computed
1
2012
21
0.020
Why?
Cerebral Veins
1
2012
16
0.020
Why?
Erythrocytes
2
2008
750
0.020
Why?
Cerebral Arteries
1
2012
56
0.020
Why?
Health Services Accessibility
1
2020
1107
0.020
Why?
Pandemics
1
2020
1707
0.020
Why?
Plasminogen Activators
1
2011
7
0.020
Why?
Heparin, Low-Molecular-Weight
1
2011
37
0.020
Why?
Radiography
1
2013
861
0.020
Why?
Quality of Life
1
2023
3200
0.020
Why?
Mice, Inbred C57BL
2
2015
6034
0.020
Why?
Analysis of Variance
1
2013
1298
0.020
Why?
Magnetic Resonance Angiography
1
2012
249
0.020
Why?
Obesity
1
2023
3131
0.020
Why?
Length of Stay
1
2015
1358
0.020
Why?
Buspirone
1
2009
5
0.020
Why?
Meperidine
1
2009
6
0.020
Why?
Shivering
1
2009
5
0.020
Why?
Adjuvants, Anesthesia
1
2009
13
0.020
Why?
Life Support Care
1
2009
44
0.020
Why?
Microspheres
1
2009
142
0.020
Why?
Mice
3
2015
18297
0.020
Why?
Microcirculation
1
2009
142
0.020
Why?
Brain Damage, Chronic
1
2008
17
0.020
Why?
Anti-Anxiety Agents
1
2009
46
0.020
Why?
Infusions, Intra-Arterial
1
2008
61
0.020
Why?
Cerebral Angiography
1
2008
121
0.020
Why?
Mice, Knockout
1
2015
3125
0.020
Why?
Blood Flow Velocity
1
2009
419
0.020
Why?
Behavior
1
2008
90
0.020
Why?
Drug Combinations
1
2009
400
0.020
Why?
Cultural Competency
1
2008
83
0.020
Why?
Enzyme Activators
1
2007
9
0.020
Why?
Infusions, Intravenous
1
2008
432
0.020
Why?
Prostaglandin D2
1
2007
22
0.020
Why?
Regression Analysis
1
2009
999
0.020
Why?
Urokinase-Type Plasminogen Activator
1
2006
25
0.020
Why?
Nitric Oxide Synthase Type II
1
2007
162
0.020
Why?
Deep Brain Stimulation
1
2009
223
0.010
Why?
Graft Survival
1
2008
523
0.010
Why?
Hydrogen Peroxide
1
2007
337
0.010
Why?
Reproducibility of Results
1
2013
3416
0.010
Why?
Recurrence
1
2008
1133
0.010
Why?
Graft Rejection
1
2008
516
0.010
Why?
Urban Population
1
2008
497
0.010
Why?
Animals, Newborn
1
2007
888
0.010
Why?
Self Efficacy
1
2008
418
0.010
Why?
Recombinant Fusion Proteins
1
2006
663
0.010
Why?
Myocardial Infarction
1
2011
1215
0.010
Why?
Program Evaluation
1
2007
952
0.010
Why?
Atrial Fibrillation
1
2008
560
0.010
Why?
Curriculum
1
2007
1079
0.010
Why?
Apoptosis
1
2008
2439
0.010
Why?
Cells, Cultured
1
2007
4118
0.010
Why?
Cytokines
1
2007
2081
0.010
Why?
Health Knowledge, Attitudes, Practice
1
2007
1408
0.010
Why?
Parents
1
2007
1394
0.010
Why?
Neurons
1
2007
1668
0.010
Why?
Child
1
2007
22693
0.000
Why?
Gonzales's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)